Cryo Cell International (CCEL) Capital Expenditures (2010 - 2026)

Cryo Cell International has disclosed Capital Expenditures across 17 years of filings, most recently posting $67065.0 for Q1 2026.

• In Q1 2026, Capital Expenditures rose 8.08% year-over-year to $67065.0; the TTM figure through Feb 2026 stood at $235487.0 (down 88.27% YoY), while the FY2025 annual figure was $230475.0, down 90.41% from the prior year.
• Capital Expenditures held at $67065.0 in Q1 2026, from $67226.0 in the prior quarter.
• Over the last five years, Capital Expenditures for CCEL reached as high as $11.2 million in Q3 2022 and fell as low as -$25011.0 in Q4 2022.
• The 5-year median for Capital Expenditures is $306970.0 (2022), against an average of $1.3 million.
• Annual changes were most pronounced in 2022 — Capital Expenditures plunged 108.93% — and 2023, when it jumped 6956.64%.
• A 5-year view of Capital Expenditures shows it stood at -$25011.0 in 2022, then jumped by 6956.64% to $1.7 million in 2023, then plunged by 99.51% to $8348.0 in 2024, then surged by 705.29% to $67226.0 in 2025, then retreated by 0.24% to $67065.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $67065.0, $67226.0, and $38788.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.